Tumor samples were micro-dissected away from normal lung tissue and RNA was extracted using Qiagen RNeasy Micro kit per manufacturers instructions. Sequencing libraries were prepared on the Illumina NeoPrep and subjected to 75 bp paired end sequencing on the Illumina NextSeq 500 platform. Fastq files for each sample were aligned against the mouse genome, build GRCm38.p4, using the STAR aligner (v2.5.2b) [25 (link)]. FeatureCounts (v1.5.0-p1) was used to quantify alignments against the mouse genomic annotations from Gencode (vM11) [26 (link)]. High purity of tumor cell derived RNA was estimated by detecting SNPs that were engineered during design of the KrasLSL-G12D allele in the Integrative Genomics Viewer [27 (link), 28 (link)]. Differentially expressed genes were identified with DESeq2 (v1.14.0) [29 (link)].